EOFLOW Co.,Ltd. (KOSDAQ:294090)
South Korea
· Delayed Price · Currency is KRW 1,490.00
-89.00 (-5.64%)
Mar 21, 2025, 5:10 PM KST
EOFLOW Revenue
In the year 2024, EOFLOW had annual revenue of 5.03B KRW, down -23.65%. EOFLOW had revenue of 477.94M in the quarter ending December 31, 2024, a decrease of -72.27%.
Revenue
5.03B
Revenue Growth
-23.65%
P/S Ratio
10.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
51.11B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| Peptron | 3.15B |
| PharmaResearch | 392.31B |
EOFLOW News
- 6 months ago - Insulet awarded $452M in damages in EOFlow case - Seeking Alpha